Open Source Pitfalls At The Biotechnology-High Technology Crossover

DM
Duane Morris LLP

Contributor

Duane Morris LLP, a law firm with more than 800 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today's legal and business challenges.
Software is eating the biotechnology world. Managers in the traditional biotechnology sector may not be familiar with open source software and related compliance issues, but these issues are bound to come up ...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Software is eating the biotechnology world. Managers in the traditional biotechnology sector may not be familiar with open source software and related compliance issues, but these issues are bound to come up as they develop technology solutions to the problems of biotechnology.

Many computer programmers like to incorporate code from open source software into software products because there is no point in reinventing the wheel for standard, simple or common software functionalities.

Open source software is software code that is typically gratis, well-vetted, and commonly used. The source code of open source software (e.g., the human-readable component of software) is made available with a license, provided by the copyright holder, to freely modify and use the software. However, use of open source software comes with strings attached. Some licenses are permissive, meaning that a user is merely required to attribute the underlying software back to the copyright holder. However, other licenses have a "copyleft" requirement for the user of the software to also make the corresponding source code available under the same licensing terms. Violation of the terms of an open source license may open the door to undesirable litigation and bad publicity. ...

To read the full article, visit the Bio-IT World website.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More